98%
921
2 minutes
20
Three-dimensional printing has revolutionized drug manufacturing and has provided a solution to the limitations associated with the conventional manufacturing method by designing complex drug delivery systems with customized drug release profiles for personalized therapies. The present investigation aims to design a gastric floating tablet with prolonged gastric floating time and sustained drug release profile. In the present study, a gastro retentive floating device (GRFD) was designed and fabricated using a fused deposition modelling (FDM)-based 3D printing technique. This device acts as a multifunctional dosage form exhibiting prolonged gastric retention time and sustained drug release profile with improved oral bioavailability in the upper gastrointestinal tract. Commercial polyvinyl alcohol (PVA) and polylactic acid (PLA) filaments were used to design GRFD, which was comprised of dual compartments. The outer sealed compartment acts as an air-filled chamber that imparts buoyancy to the device and the inner compartment is filled with a commercial propranolol hydrochloride immediate-release tablet. The device is designed as a round-shaped shell with a central opening of varying size (1 mm, 2 mm, 3 mm, and 4 mm), which acts as a drug release window. Scanning electron microscope (SEM) images were used to determine morphological characterization. The in vitro buoyancy and drug release were evaluated using the USP type II dissolution apparatus. All the designed GRFDs exhibit good floating ability and sustained drug release profiles. GRFDs fabricated using PLA filament show maximum buoyancy (>24 h) and sustained drug release for up to 10 h. The floating ability and drug release from the developed devices were governed by the drug release window opening size and the filament material affinity towards the gastric fluid. The designed GRFDs show great prospects in modifying the drug release characteristics and could be applied to any conventional immediate-release product.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490505 | PMC |
http://dx.doi.org/10.3390/polym15173554 | DOI Listing |
BMC Biotechnol
September 2025
Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.
Fundam Clin Pharmacol
October 2025
Postgraduate Program in Pharmaceutical Science, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
This review highlights the integration of drug repurposing and nanotechnology-driven delivery strategies as innovative approaches to enhance the antifungal activity of statins against mucosal candidiasis, providing a framework for future translational research and clinical application. The rising prevalence of antifungal resistance and virulence factors of Candida albicans underscore the limitations of current therapies. Statins, commonly used as lipid-lowering agents, have emerged as attractive repurposed drug candidates due to their ability to interfere with fungal ergosterol biosynthesis and Ras-mediated signaling pathways.
View Article and Find Full Text PDFNat Nanotechnol
September 2025
Department of Bioengineering, Rice University, Houston, TX, USA.
Maintaining safe and potent drug levels in vivo is challenging. Multidomain peptides assemble into supramolecular hydrogels with a well-defined, highly porous nanostructure that makes them attractive for drug delivery. However, their ability to extend release is typically limited by rapid drug diffusion.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and Engineering, Tianjin University, Tianjin, 300350, PR China. Electronic address:
Balancing antibacterial efficacy, mechanical integrity, and biocompatibility remains a critical challenge in drug release systems for wound dressings. Many antimicrobial agents exhibit inherent cytotoxicity, compromising cell viability and tissue compatibility. To address this, an Absorbable Gelatine Sponge was synthetised based on high-viscosity hydroxypropyl methylcellulose (HPMC K100M) and loaded with silver citrate nanorods (AgCit), which confine silver nanoparticles to enable controlled ion release.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, 50603, Malaysia. Electronic address:
This study aimed to characterize, in vitro dissolution, and evaluate the release kinetics of salicylamide in capsule shells made from κ-carrageenan-HPMC. The capsule shell was prepared using the dipping method with CRG: HPMC (1:1, 1:2, 1:3) ratio, supplemented with sorbitol and antifoam silicone emulsion. Characterization was conducted using FTIR, SEM-EDX mapping, AFM, hardness, and swelling degree experiments.
View Article and Find Full Text PDF